C&B EUREKA INNOVATIONS CO., LIMITED:25 μΩ / ±0.1% / ±15 ppm/°C High-Precision Shunt Module Launched — ±0.3% Accuracy Across the Full Temperature Range Without Temperature Compensation Sep 3, 2026 07:43AM

SHENZHEN, China, Sept. 03, 2026 (GLOBE NEWSWIRE) -- C&B EUREKA INNOVATIONS CO., LIMITED / C&B RESI - In new energy vehicles, DC charging equipment, and electric construction machinery, current sensing is critical to energy management, power control, and system protection. As current levels increase, measurement errors caused by shunt self-heating, temperature variations, and thermal EMF at connection points become more significant. The C&B RESI HRES8436BL025MST0... (continue reading...)


Javier Loya Says Hispanic Voters Are Setting the Terms as Proyecto Lone Star Launches in Texas Sep 3, 2026 07:42AM

AUSTIN, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Bienvenido In Action and Hispanic Republicans of Texas have launched Proyecto Lone Star, a Hispanic voter outreach initiative authorized by the Republican National Committee and built to establish lasting civic infrastructure across Texas ahead of the 2026 midterm elections.

The initiative reflects a broader recalibration in American politics, in which Hispanic voters are no longer approached as a demographic to be... (continue reading...)


CoinShares XBT Provider AB (publ) - 2017 Issuance Programme Change of FX Source/FX Rate Sep 3, 2026 07:37AM

CoinShares XBT Provider AB (publ)LEI: 549300HGWKR2Q5T8GK64

3 September 2026

CoinShares XBT Provider AB (publ)

Issuance Programme for the issue of

Bitcoin Tracker Certificates and Ethereum Tracker Certificates

Change of FX Rate/FX Source

CoinShares XBT Provider AB (publ) (the “Issuer”) announces that, due to a change in the FX price source used by Compass Financial Technologies SA (the “Calculation Agent”) or any other Calculation Agent specified in the Final... (continue reading...)


CoinShares XBT Provider AB (publ) - 2015 Issuance Programme Change of FX Source/FX Rate Sep 3, 2026 07:32AM

CoinShares XBT Provider AB (publ)LEI: 549300HGWKR2Q5T8GK64

3 September 2026

CoinShares XBT Provider AB (publ) 

Issuance Programme for the issue of Bitcoin Tracker Certificates

Change of FX Source/FX Rate

CoinShares XBT Provider AB (publ) (the “Issuer”) announces that, due to a change in the FX price source used by Compass Financial Technologies SA (the “Calculation Agent”) or any other Calculation Agent specified in the Final Terms applicable to the relevant... (continue reading...)


Hillman Completes Acquisition of Kanebridge Sep 3, 2026 07:30AM

CINCINNATI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products, announced it has completed its previously announced acquisition of Kanebridge, LLC (“Kanebridge”), a leading master distributor of industrial fasteners, for a purchase price of approximately $315 million, subject to customary adjustments. The acquisition was first announced on August 3, 2026.

Kanebridge supplies... (continue reading...)


More Globe Newswire

View Older Stories

Sep 3, 2026 07:30AM Volatus Aerospace Selected for Canada’s Defence Drone Initiative Marketplace
Sep 3, 2026 07:30AM Electra to Showcase Growing North American Critical Minerals Platform at September Investor and Industry Conferences
Sep 3, 2026 07:30AM FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
Sep 3, 2026 07:30AM TG Therapeutics to Participate in the Cantor Global Healthcare Conference
Sep 3, 2026 07:30AM Trevi Therapeutics to Participate in Upcoming September Conferences
Sep 3, 2026 07:30AM ESGold Commences Diamond Drilling at Its Montauban Project, Québec
Sep 3, 2026 07:30AM Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York
Sep 3, 2026 07:30AM Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer
Sep 3, 2026 07:30AM FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
Sep 3, 2026 07:30AM Morocco Strategic Minerals Corp. Completes Sale of Initial 51% Interest in Sakami Property in Québec
Sep 3, 2026 07:30AM Kobo Resources Extends Gold Mineralisation to the North at Kossou with Multiple High-Grade Drill Intercepts
Sep 3, 2026 07:30AM Rekor Eliminates Approximately $10 Million in Liabilities and Generates More Than $2 Million in Annual Savings
Sep 3, 2026 07:30AM Saia Provides July and August LTL Operating Data
Sep 3, 2026 07:30AM Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting
Sep 3, 2026 07:30AM Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences
Sep 3, 2026 07:30AM Crescent Biopharma to Present at September Investor Conferences
Sep 3, 2026 07:15AM MiniLuxe Announces New Mansfield Studio Opening Through Joint Venture with Entrepreneur Vera Vos-Lexmond
Sep 3, 2026 07:13AM Wood Mackenzie: Natural Carbon Sinks Absorb 40% of Human CO2 Emissions and Are Not Valued in Most Climate Models
Sep 3, 2026 07:05AM Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
Sep 3, 2026 07:05AM Kraig Biocraft Laboratories Highlighted by Tech Times for Advancing Spider Silk from Science Fiction Toward Commercial Reality
Sep 3, 2026 07:05AM Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
Sep 3, 2026 07:05AM Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
Sep 3, 2026 07:01AM Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 
Sep 3, 2026 07:00AM EdgeMode secures FINRA completion of Form 211 review, permitting sponsoring market maker to initiate quotations
Sep 3, 2026 07:00AM Stallion Completes Ground Gravity, Identifies Three New Priority Target Areas At Stone Island
Sep 3, 2026 07:00AM Rubicon Organics Announces Details of Annual General Meeting
Sep 3, 2026 07:00AM Real Matters Announces Departure of Chief Financial Officer
Sep 3, 2026 07:00AM CANADA’S FAVOURITE COOKIE BRAND CELEBRATES 25TH STORE OPENING IN PORT CREDIT MISSISSAUGA AS NATIONAL FRANCHISE EXPANSION ACCELERATES
Sep 3, 2026 07:00AM BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026 07:00AM GXO Expands Technology Organization To Enable Scale and Resilience and Accelerate Innovation
Sep 3, 2026 07:00AM Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026 07:00AM Cartesian Therapeutics to Participate in Upcoming Investor Conferences
Sep 3, 2026 07:00AM Victoria’s Secret & Co. Reports Second Quarter 2026 Results
Sep 3, 2026 07:00AM Aurora Mobile Showcases AI Solutions for Customer Engagement at Tokyo’s AI Expo Summer 2026
Sep 3, 2026 07:00AM Alternative Ballistics Appoints Sertan Ayçiçek to Help Drive Global Expansion, Strategic Investment and Commercial Growth
Sep 3, 2026 07:00AM Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial
Sep 3, 2026 07:00AM Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference
Sep 3, 2026 07:00AM Gyre Therapeutics to Participate in Upcoming September Investor Conferences
Sep 3, 2026 07:00AM C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd I
Sep 3, 2026 07:00AM LeonaBio to Participate in Cantor Global Healthcare Conference 2026
Sep 3, 2026 07:00AM Climb Bio Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy
Sep 3, 2026 07:00AM Breckenridge Distillery and Southern Glazer’s Expand Partnership Across New York and California
Sep 3, 2026 07:00AM Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026 07:00AM Avalo Therapeutics to Participate in Upcoming Investor Conferences
Sep 3, 2026 07:00AM GXO Expands Technology Organization To Enable Scale and Resilience and Accelerate Innovation
Sep 3, 2026 07:00AM BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026 07:00AM Nu-Tek BioSciences’ Animal-Free Raw Materials Drive Cell Culture Media Evolution, Supply Security at CPHI Global 2026 in Milan
Sep 3, 2026 06:56AM MT Højgaard Holding A/S: Enemærke & Petersen to refurbish Lærkeparken in Odense
Sep 3, 2026 06:55AM ScottsMiracle-Gro to Acquire Black Kow in Alignment with SMG 2.0 Growth Strategy
Sep 3, 2026 06:55AM ANI Pharmaceuticals to Present at September Investor Conferences
View Older Stories